WB and immunofluorescence analysis further corroborated the decrease in α‐SMA and Col1A1 expression in the skin of BLM‐SSc mice treated with anti‐IL‐17RA mAb (Figure 7F,G). This evidence concerns the gene COL1A1 and systemic sclerosis.